Skip to main content
main-content

29.04.2019 | Breast Cancer Imaging and Screening (N Sharma, Section Editor) | Ausgabe 2/2019

Current Breast Cancer Reports 2/2019

Diffusion-Weighted Magnetic Resonance Imaging of the Breast: an Accurate Method for Measuring Early Response to Neoadjuvant Chemotherapy?

Zeitschrift:
Current Breast Cancer Reports > Ausgabe 2/2019
Autoren:
Amar N. Kanani, Nisha Sharma, David L. Buckley
Wichtige Hinweise
This article is part of the Topical Collection on Breast Cancer Imaging and Screening

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abstract

Purpose of Review

Accurate prediction of early treatment response in patients receiving neoadjuvant chemotherapy for breast cancer is essential to provide patients with the best care. Diffusion-weighted magnetic resonance imaging (DWI) provides a novel approach to distinguishing responders from non-responders. This article aims to review the literature regarding the accuracy of DWI in predicting patients who will respond to neoadjuvant chemotherapy at an early stage within their treatment pathway.

Recent Findings

The initial search yielded 11,171 articles. After careful review, 19 of these articles were found to adhere to the inclusion criteria. Despite the varied research methods and data analysis across the studies, 16 out of 19 of these studies (84%) demonstrated DWI to be an accurate predictor of neoadjuvant chemotherapy response.

Summary

These results are promising; however, further multi-centre studies with larger sample sizes, homogenous imaging and treatment parameters and formal assessment of pathological response are required to accurately evaluate the use of DWI as an early predictor of neoadjuvant chemotherapy response in patients with breast cancer.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 2/2019

Current Breast Cancer Reports 2/2019 Zur Ausgabe

Local-Regional Evaluation and Therapy (DM Euhus, Section Editor)

Local-Regional Evaluation and Therapy (D Euhus, Section Editor)

Breast Cancer Imaging and Screening (N Sharma, Section Editor)

Management of B3 Lesions—Practical Issues

Breast Cancer Imaging and Screening (N Sharma, Section Editor)

Interval Cancers and Duty of Candour, a UK Perspective

  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise